Download presentation
Presentation is loading. Please wait.
Published byPeregrine Norman Modified over 9 years ago
1
ABAB p53 caffeine doxo - - - 24h 48h - + + - + Casp8 Casp10 FADD FLIP Bcl-2 BIM BID PUMA Bax Bak XIAP cIAP-1 cIAP-2 GAPDH MFI untreated 3,3x10 3 MFI doxo 9,8x10 3 MFI untreated 3,3x10 3 MFI caffeine +doxo 8,6x10 3 SHEP Supplementary Figure 1 MFI isotype 1,1x10 2 MFI isotype 1,1x10 3 events 100 80 60 40 20 0 0 10 2 10 3 10 4 10 5 DR5-APC isotype untreated doxo events 100 80 60 40 20 0 0 10 2 10 3 10 4 10 5 DR5-APC isotype untreated caffeine +doxo
2
CDCD events 150 100 50 0 0 10 2 10 3 10 4 10 5 DR5-APC events 150 100 50 0 0 10 2 10 3 10 4 10 5 DR5-APC MFI doxo 7,2x10 3 MFI doxo 1,3x10 4 DR5 expression of cells in G0/G1 DR5 expression of cells in G2 SHEP Supplementary Figure 1 SHEP events 100 75 50 25 0 0 10 1 10 2 10 3 DR5-FITC 75 50 25 0 specific apoptosis (%) mock DR5 overexpression NS TRAIL MFI mock 6,7x10 0 MFI DR5 overexpression 3,6x10 1 MFI isotyp 2,7x10 0 isotyp mock DR5 overexpression
3
50 25 0 specific apoptosis (%) control caffeine untreated TRAIL doxo doxo+TRAIL * NS A * HCT116 Supplementary Figure 2
4
BCBC Casp8 Casp10 FADD FLIP Bcl-2 Bcl-XL BIM BID NOXA Bax Bak XIAP cIAP-2 GAPDH p53 caffeine doxo -- -24h 48h - ++ - + events 100 80 60 40 20 0 0 10 2 10 3 10 4 10 5 DR5-APC isotyp untreated doxo events 100 80 60 40 20 0 0 10 2 10 3 10 4 10 5 DR5-APC isotyp untreated caffeine +doxo MFI untreated 1,8x10 3 MFI doxo 4,9x10 3 MFI untreated 1,8x10 3 MFI caffeine +doxo 2,8x10 3 HCT116 Supplementary Figure 2 MFI isotyp 1,4x10 2
5
D events 0 50 100 150 200 250 k propidium iodide 400 300 200 100 0 events 0 50 100 150 200 250 k propidium iodide 400 300 200 100 0 events 0 50 100 150 200 250 k propidium iodide 400 300 200 100 0 events 0 50 100 150 200 250 k propidium iodide 25,4%78,4% 24,8%27,2% 300 200 100 0 untreated doxo caffeine caffeine+doxo HCT116 Supplementary Figure 2
6
E p-HistonH3 Ser10 0 50 100 150 200 250 k propidium iodide 10 5 10 4 10 3 10 2 0 p-HistonH3 Ser10 0 50 100 150 200 250 k propidium iodide p-HistonH3 Ser10 0 50 100 150 200 250 k propidium iodide p-HistonH3 Ser10 0 50 100 150 200 250 k propidium iodide 10 5 10 4 10 3 10 2 0 10 5 10 4 10 3 10 2 0 10 5 10 4 10 3 10 2 0 3,6% 21,8% 0,2% 78,2% 3,1% 21,7% 3,8% 23,4% untreated doxo caffeine caffeine+doxo HCT116 Supplementary Figure 2
7
ABAB events 100 80 60 40 20 0 0 10 2 10 3 10 4 10 5 DR5-APC isotype untreated dexa events 100 80 60 40 20 0 0 10 2 10 3 10 4 10 5 DR5-APC isotype untreated caffeine +dexa MFI untreated 3,3x10 3 MFI dexa 4,6x10 3 MFI untreated 3,3x10 3 MFI caffeine +dexa 4,3x10 3 events 100 80 60 40 20 0 0 10 2 10 3 10 4 10 5 DR5-APC isotype untreated MTX events 100 80 60 40 20 0 0 10 2 10 3 10 4 10 5 DR5-APC isotype untreated caffeine +MTX MFI untreated 3,3x10 3 MFI MTX 1,1x10 5 MFI untreated 3,3x10 3 MFI caffeine +MTX 6,4x10 4 SHEP Supplementary Figure 3 MFI isotype 1,1x10 2 MFI isotype 1,1x10 2 MFI isotype 1,1x10 2 MFI isotype 1,1x10 2
8
HCT116 Supplementary Figure 4 TRAIL 1,0 0,75 0,5 0,25 0 FCS withdrawel 0 0,25 0,5 0,75 1,0 TRAIL 1,0 0,75 0,5 0,25 0 mimosine 0 0,25 0,5 0,75 1,0
9
HCT116 Supplementary Figure 4 TRAIL 1,0 0,75 0,5 0,25 0 irradiation 0 0,25 0,5 0,75 1,0
10
Supplementary Figure 5 A B 100 80 60 40 20 0 events (%) 0 50 100 150 200 250 k propidium iodide mock sicyclinE mock sicyclinB 100 80 60 40 20 0 events (%) 0 50 100 150 200 250 k propidium iodide cyclinE cyclinB parental sicyclinB sicyclinE GAPDH HCT116 75 50 25 0 specific apoptosis (%) mock sicyclinB sicyclinE * TRAIL *
11
A B 100 80 60 40 20 0 events (%) 0 50 100 150 200 250 k propidium iodide mock sicyclinE mock sicyclinB 100 80 60 40 20 0 events (%) 0 50 100 150 200 250 k propidium iodide cyclinE cyclinB parental sicyclinB sicyclinE GAPDH CEM Supplementary Figure 6 75 50 25 0 specific apoptosis (%) mock sicyclinB sicyclinE * TRAIL *
12
A events 0 50 100 150 200 250 k propidium iodide 600 400 200 0 events 0 50 100 150 200 250 k propidium iodide 1000 800 600 400 200 0 events 0 50 100 150 200 250 k propidium iodide 1000 800 600 400 200 0 events 0 50 100 150 200 250 k propidium iodide 11,4%19,1% 10,9%10,7% 600 400 200 0 untreated doxo caffeine caffeine+doxo ALL-199 Supplementary Figure 7
13
BCBC untreated TRAIL doxo doxo+TRAIL * NS 50 25 0 specific apoptosis (%) control caffeine 50 25 0 specific apoptosis (%) control caffeine untreated TRAIL doxo doxo+TRAIL * NS * * ALL-199 ALL-4S Supplementary Figure 7
14
D cyclinE cyclinB parental sicyclinB sicyclinE GAPDH ALL-199 Supplementary Figure 7 25 0 specific apoptosis (%) mock sicyclinB sicyclinE * TRAIL *
15
Supplementary Figure 7 E cyclinE cyclinB parental sicyclinB sicyclinE GAPDH ALL-4S 25 0 specific apoptosis (%) mock sicyclinB sicyclinE * TRAIL *
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.